Awake Life Sciences LLP
About Awake Life Sciences LLP
Data last updated:
Awake Life Sciences LLP is a limited liability partnership (LLP) based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 March 2015 and has been in existence for over 11 years.
The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAD-5626. Its GSTIN is 07ABCFA1689C1ZP (Delhi).
The LLP has a total obligation of contribution of ₹5 Lakh. It is led by designated partners Chandan Chopra and Binny Chopra.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at S – 94 Second Floor Unit No. 2A Okhla Industrial Area Phas, E – 2, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹23.45 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹39.07 Lakh (net margin 1.7%) and EBITDA of ₹38.41 Lakh (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 173% over three years and 135% over five years.
Court records list 4 cases involving the LLP, including 4 filed by the LLP; 3 cases are pending.
Company details
Contact details
Awake Life Sciences LLP's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressS – 94 Second Floor Unit No. 2A Okhla Industrial Area Phas, E – 2, New Delhi, Delhi, India – 110020
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Awake Life Sciences LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Awake Life Sciences LLP
FY 2025 filings availableAwake Life Sciences LLP reported revenue of ₹23.45 Cr (up 228% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 135% over five years, including 228% growth in the latest year. EBITDA fell 54% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹39.07 Lakh | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 1.7% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Awake Life Sciences LLP, buy the company report.
Designated partners of Awake Life Sciences LLP
Awake Life Sciences has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandan Chopra Also directs: Core Technomed LLP, Zymes Tech Private Limited, Zymes Bioscience Private Limited and 1 more | Designated Partner | 24 May 2018 | 8 Years 5 Months | Current |
| Binny Chopra Also directs: Zalix Pharmaceuticals Private Limited | Designated Partner | 18 Mar 2015 | 11 Years 7 Months | Current |
Legal cases
Awake Life Sciences LLP has 4 court cases on record: 4 filed by Awake Life Sciences. 3 cases are pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 3 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Cheque dishonour complaint | Filed by the company against Myzen Enterprises Pvt Ltd and 2 others | Pending |
| District court, South East, Delhi | Criminal case | Filed by the company against Gaurav Pharmaceuticals | Pending |
| District court, South East, Delhi | Criminal case | Filed by the company against Bajarangi Pharmaceuticals | Pending |
| District court, South East, Delhi | Criminal case | Filed by the company against an individual | Disposed |
To see the full case history of Awake Life Sciences LLP, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Awake Life Sciences LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Awake Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07ABCFA1689C1ZP | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Awake Life Sciences LLP, buy the company report.
Recent activity
Awake Life Sciences LLP has 3 designated partner changes on record since 2015: 2 appointments and 1 cessation. The latest: Chandan Chopra was appointed as Designated Partner on 24 May 2018.
Frequently asked questions
Awake Life Sciences is an active limited liability partnership based in New Delhi, Delhi, India. The LLP works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 March 2015 (11+ years old) and is registered under LLPIN AAD-5626.
Awake Life Sciences has 2 current designated partners:
- Chandan Chopra - Designated Partner
- Binny Chopra - Designated Partner
The latest financial statements of Awake Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Awake Life Sciences is 07ABCFA1689C1ZP, registered in Delhi.
The LLPIN (Limited Liability Partnership Identification Number) of Awake Life Sciences is AAD-5626. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Awake Life Sciences has 4 court cases on record: 4 filed by the LLP. 3 are pending.
Awake Life Sciences was incorporated on 18 March 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Chandan Chopra was appointed as Designated Partner on 24 May 2018. Rohit Khanna ceased to be Designated Partner on 24 May 2018. Binny Chopra was appointed as Designated Partner on 18 Mar 2015.
The registered office of Awake Life Sciences is at S – 94 Second Floor Unit No. 2A Okhla Industrial Area Phas, E – 2, New Delhi, Delhi, India – 110020.
Awake Life Sciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.